Skip to main content
Edwards Lifesciences Logo
Edwards Lifesciences Logo

SAPIEN 3 Ultra transcatheter heart valve

SAPIEN 3 Ultra
SAPIEN 3 Ultra
SAPIEN 3 Ultra
Structural Heart THV banner image
Structural Heart THV banner image
Structural Heart THV banner image

Built upon the proven SAPIEN platform, the SAPIEN 3 Ultra transcatheter heart valve is designed with your patient's future needs in mind.

Taller, textured outer skirt1

  • Approximately 40% increased outer skirt*
  • Textured PET material
  • 14F sheath compatibility

*Compared to the Edwards SAPIEN 3 valve

Edwards Commander Delivery System
Edwards Commander Delivery System
Edwards Commander Delivery System

Edwards Commander Delivery System: For predictable, proven results3

eSheath Introducer Set Image
eSheath Introducer Set Image
eSheath Introducer Set Image

Edwards eSheath Introducer Set: For controlled deployment1

TAVI procedural animation using the SAPIEN 3 Ultra system

‌

Learn more about SAPIEN 3 Ultra TAVI* clinical evidence

*TAVI = Transcatheter Aortic Valve Implantation 

Visit website for heart team

References

1. Data on File at Edwards Lifesciences
2. Tarantini G, Nai Fovino L, Le Prince P, et al. Coronary Access and Percutaneous Coronary Intervention Up to 3 Years After Transcatheter Aortic Valve Implantation With a Balloon-Expandable Valve. Circ Cardiovasc Interv. 2020;13(7):e008972.
3. Thourani VH, et al. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. Lancet. 2016 May 28;387(10034):2218-25)
4. Mack MJ, et al. Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients. N Engl J Med. 2019 May 2;380(18):1695-1705)
†Data on file at Edwards Lifesciences

Medical device for professional use

Medical device for professional use

For a listing of indications, contraindications, precautions, warnings, and potential adverse events, please refer to the Instructions for Use (consult eifu.edwards.com where applicable).